Clinical Trial Update: Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study completed to compare the relative bioavailability of a fixed-dose combination of dolutegravir and lamivudine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Epivir (Lamivudine)
• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED